Search Results - "Brozos Vázquez, E."

Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers by Brozos-Vázquez, E M, Rodríguez-López, C, Cortegoso-Mosquera, A, López-Landrove, S, Muinelo-Romay, L, García-González, J, López-López, R, León-Mateos, L

“…The central nervous system (CNS) is one of the most frequent metastatic sites of various cancers, including lung cancer, breast cancer and melanoma. The…”
Get full text

SEOM clinical guidelines for anaemia treatment in cancer patients (2020) by Escobar Álvarez, Y., de las Peñas Bataller, R., Perez Altozano, J., Ros Martínez, S., Sabino Álvarez, A., Blasco Cordellat, A., Brozos Vázquez, E., Corral Jaime, J., García Escobar, I., Beato Zambrano, C.

“…Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of…”
Get full text

Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence by García-Escobar, I., Brozos-Vázquez, E., Gutierrez Abad, D., Martínez-Marín, V., Pachón, V., Muñoz Martín, A. J.

“…Venous thromboembolic disease (VTED) is a common and clinically important complication in patients with cancer, contributing to its mortality and morbidity…”
Get full text

Pleiotropic effects of heparins: does anticoagulant treatment increase survival in cancer patients? by García-Escobar, I., Beato-Zambrano, C., Muñoz Langa, J., Brozos Vázquez, E., Obispo Portero, B., Gutiérrez-Abad, D., Muñoz Martín, A. J.

“…The association between venous thromboembolism (VTE) and cancer has been recognized for more than 100 years. Numerous studies have been performed to…”
Get full text

Correction to: SEOM clinical guidelines for anaemia treatment in cancer patients (2020) by Escobar Álvarez, Y., de las Peñas Bataller, R., Perez Altozano, J., Ros Martínez, S., Sabino Álvarez, A., Blasco Cordellat, A., Brozos Vázquez, E., Corral Jaime, J., García Escobar, I., Beato Zambrano, C.

Get full text

Is there any affordable and reliable score in local gastric cancer? by Cousillas Castiñeiras, A., Gallardo Martin, E., Fernández Montes, A., Covela Rúa, M., Carmona Campos, M., Salgado Fernandez, M., Pellón Augusto, M., Vidal Insua, Y., Gonzalez Villarroel, P., Martínez-Lago, N., De la Cámara Gómez, J., Candamio Folgar, S., Brozos Vázquez, E., Fernandez, M. Jorge, Vázquez Rivera, F., Méndez Méndez, J., Quintero Aldana, G., Constenla, M.

Get full text

HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme by Herranz, M., Padín-Iruegas, M. E., Martínez-Lago, Nieves, Losada, S. Aguín, Raña-Díez, P., Vázquez, E. Brozos, Carrera, J. J., Antúnez, J. R., Ruibal, A., López-López, R.

“…Glioblastoma multiforme (GBM) is the most common brain tumor in adults. The role of high in normal-1 (HIN-1) as a potential biomarker in combating this disease…”
Get full text

P-122 Vitamin D-based score in gastric cancer by Cousillas Castiñeiras, A., Gallardo Martin, E., Fernández Montes, A., Covela-Rúa, M., Martínez-Lago, N., Salgado Fernandez, M., Pellón Augusto, M., Gonzalez Villarroel, P., de la Cámara Gómez, J., Brozos Vázquez, E., Vázquez-Rivera, F., Méndez Méndez, J.

Get full text

P-89 Validation of the prognostic significance of the dNLR (2.2) in a population-based cohort of metastatic colorectal cancer patients treated with oxaliplatin-based first-line therapy by Martelo, M. Pérez, Fernández, J. Álvarez, Nallib, I. Abdulkader, Vázquez, E. Brozos, Rivera, F. Vázquez, Ínsua, Y. Vidal, Folgar, S. Candamio, López, R. López, Bañobre, J. Ruiz

Get full text

P-11 Venous thromboembolism in colorectal cancer patients with BRAF mutation by Ortega Morán, L., Pesántez, D., Brozos Vázquez, E., Fernández Garay, D., Lobo de Mena, M., Ribera Fernández, P., Sánchez Cánovas, M., Salgado Fernandez, M., García Pérez, E., Iriarte Moncho, E., Morón García, B., Font, C., Gallardo, E., Pérez Altozano, J., Muñoz Martín, A.

Get full text

437P Designing clinical profiles that influence the discordance of RAS mutations in blood and tissue: Sidedness and anatomical metastasis as factors of disagreement by Brozos-Vázquez, E., Lago-Lestón, R., Covela-Rúa, M., De la Cámara-Gómez, J., Montes, A. Fernandez, Candamio-Folgar, S., Muinelo-Romay, L., Vidal-Insua, Y., Vázquez-Rivera, F., López-Rodríguez, R., Blanco-Freire, C., Ferreirós-Vidal, I., Lopez, R. Lopez

Get full text

P-41 Understanding the clinical profiles that influence the concordance of RAS mutations between blood and tissue to guide therapy in metastatic colorectal cancer by Vázquez, E. Brozos, Lago-Lestón, R., Covela-Rúa, M., Cámara-Gómez, J. De la, Fernández-Montes, A., Folgar, S. Candamio, Ínsua, Y. Vidal, Vázquez-Rivera, F., López-Rodríguez, R., Blanco-Freire, C., Ferreirós-Vidal, I., Muinelo-Romay, L., López-López, R.

Get full text

PO-20: Incidence of venous thromboembolism in patients with BRAF-mutated colorectal cancer by Morán, L. Ortega, Pesántez, D., Vázquez, E. Brozos, Garay, D. Fernández, de Mena, M. Lobo, Fernández, P. Ribera, Cánovas, M. Sánchez, Salgado, M., Pérez, E. García, Moncho, E. Iriarte, García, B. Morón, Font, C., Gallardo, E., Altozano, J. Pérez, Martín, A. Muñoz

Get full text

PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study by Salgado, M., Molina, R., Vázquez, E. Brozos, Martínez, E., Cillán, E., Fullana, T., Villa, J.C., Lobo, M., Masvidal, M., Porta, R., Campos, B., Garicano, F., Pampols, M., Fernández, I., Font, C., Martínez, P., Gutiérrez, D., Horvath, E., Costa, A.L., Malheiro, M., Arias, D., for the CARTAGO study group

Get full text

P-43 Ramucirumab effectiveness in patients with advanced gastric cancer or gastro-esophageal junction adenocarcinoma in clinical practice in Spain: Sub-analysis of RAMIS study by Longo, F., Fernandez, M. Jorge, Tur, R. Yaya, Montes, A. Fernández, Lago, N. Martínez, Vázquez, E. Brozos, Urtasun, J. Aparicio, Aldana, G. Quintero, Barbancho, E. Ceballos, Orra, E. Buxó, Muñoz, A. Lopez, Augusto, M. Pellón, Villaverde, R. Molina, Díaz-Paniagua, L., Serdà, P. Cerdà, López-Leiva, P., Martín-Carnicero, A., Castiñeiras, A. Cousillas, Bouzas, L. París, Paredes, B. García, Reinoso, C. Romero, Sedano, M. Ortega

Get full text

P-123 Outcomes and predictive factors of regorafenib benefit in patients with metastatic colorectal cancer in a real-life setting by Lago, N. Martínez, Lopez, B. Carnero, Gomez, J. De la Cámara, Vázquez-Rivera, F., Montes, A. Fernández, Dios, N. de, Maseda, A. Carral, Augusto, M. Pellón, Folgar, S. Candamio, Reboredo-Lopez, M., Fernandez, M. Salgado, Martin, E. Gallardo, Covela-Rúa, M., Suarez, B. Graña, Campos, M. Carmona, Vázquez, E. Brozos, Rendo, C. Reboredo, Aldana, G. Quintero, Ventura, C. Grande, Ínsua, Y. Vidal, Méndez, J. Méndez

Get full text

P-219Is there any affordable and reliable score in local gastric cancer? by Cousillas Castiñeiras, A, Gallardo Martin, E, Fernández Montes, A, Covela Rúa, M, Carmona Campos, M, Salgado Fernandez, M, Pellón Augusto, M, Vidal Insua, Y, Gonzalez Villarroel, P, Martínez-Lago, N, De la Cámara Gómez, J, Candamio Folgar, S, Brozos Vázquez, E, Fernandez, M Jorge, Vázquez Rivera, F, Méndez Méndez, J, Quintero Aldana, G, Constenla, M

Get full text

TEMPORARY REMOVAL: PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study by Salgado, M, Molina, R, Vázquez, E Brozos, Martínez, E, Cillán, E, Fullana, T, Villa, J C, Lobo, M, Masvidal, M, Porta, R, Campos, B, Garicano, F, Pampols, M, Fernández, I, Font, C, Martínez, P, Gutiérrez, D, Horvath, E, Costa, A L, Malheiro, M, Arias, D, For The Cartago Study Group

“…The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the…”
Get full text

TEMPORARY REMOVAL: PO-20: Incidence of venous thromboembolism in patients with BRAF-mutated colorectal cancer by Morán, L Ortega, Pesántez, D, Vázquez, E Brozos, Garay, D Fernández, de Mena, M Lobo, Fernández, P Ribera, Cánovas, M Sánchez, Salgado, M, Pérez, E García, Moncho, E Iriarte, García, B Morón, Font, C, Gallardo, E, Altozano, J Pérez, Martín, A Muñoz

“…The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the…”
Get full text

Differences in outcome according to chemotherapy backbone and maintenance treatment in HER2 positive metastatic gastric cancer (GC) or gastroesophageal junction (GEJ) by Martinez Lago, N., Candamio Folgar, S., Grande Ventura, C., Salgado Fernandez, M., De la Camara Gomez, J., Méndez Méndez, J.C., Arias Ron, D., Vazquez, F., Reboredo Lopez, M., Vidal Ínsua, Y., Graña Suarez, B., Jorge Fernandez, M., Brozos Vazquez, M.E., Pellon Augusto, M.L., Prato Varela, J., Gonzalez Villarroel, P., Fernandez Montes, A.

Get full text